Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-03-18
ACLXArcellx, Inc.Gilson MichelleCFOS - Sale$69.34-6,8259,485-42%-$473,255
D
2024-03-15
ACLXArcellx, Inc.Ware Olivia CDirS - Sale+OE$70.40-9,0000-100%-$633,582
D
2024-03-15
CRSPCrispr Therapeutics AGPrasad RajuCFOS - Sale+OE$72.69-3,5246,476-35%-$256,160
D
2024-03-15
CRSPCrispr Therapeutics AGKulkarni SamarthCEOS - Sale+OE$72.48-20,000408,122-5%-$1,449,628
D
2024-03-14
RGNXRegenxbio Inc.Mills Kenneth T.Pres, CEOS - Sale+OE$21.86-15,000408,035-4%-$327,942
2024-03-14
TWSTTwist Bioscience CorpCho DennisSee RemarksS - Sale$34.60-9381,3630%-$3,218
2024-03-15
AIMAim Immunotech Inc.Appelrouth StewartDirP - Purchase$0.33+90,910239,765+61%+$30,000
2024-03-15
AIMAim Immunotech Inc.Equels Thomas KCEO, PresP - Purchase$0.33+75,758716,455+12%+$25,000
2024-03-15
AIMAim Immunotech Inc.Rodino Peter W IIICOO, Secretary, Gen. CounselP - Purchase$0.33+37,879181,718+26%+$12,500
M
2024-03-13
ADMAAdma Biologics, Inc.Elms SteveDirS - Sale$6.11-1,038,2842,653,828-28%-$6,339,418
M
2024-03-14
KYMRKymera Therapeutics, Inc.Booth BruceDirS - Sale$40.25-127,543806,697-14%-$5,133,263
2024-03-13
MRNAModerna, Inc.Afeyan NoubarDirS - Sale$108.54-15,00011,797,9690%-$1,628,031
D
2024-03-14
NBIXNeurocrine Biosciences IncBenevich EricChief Commercial OfficerS - Sale+OE$139.38-75,00040,778-65%-$10,453,418
D
2024-03-13
NBIXNeurocrine Biosciences IncPops Richard FDirS - Sale+OE$140.33-23,20029,512-44%-$3,255,621
D
2024-03-13
NBIXNeurocrine Biosciences IncDelaet IngridChief Regulatory OfficerS - Sale+OE$140.14-3,0007,507-29%-$420,419
DM
2024-03-13
VCELVericel CorpColangelo DominickPres, CEOS - Sale+OE$44.35-35,000194,870-15%-$1,552,075
A
2024-03-08
VCELVericel CorpFlynn Sean C.SVP, GCS - Sale$45.33-8,115167-98%-$367,853
DM
2024-03-12
RXRXRecursion Pharmaceuticals, Inc.Secora MichaelCFOS - Sale+OE$10.74-50,0001,204,179-4%-$537,190
2024-03-14
CGTXCognition Therapeutics IncRicciardi LisaCEO, PresP - Purchase$1.75+5,700291,345+2%+$9,975
M
2024-03-11
KYMRKymera Therapeutics, Inc.Atlas Venture Fund X, L.P.10%S - Sale$42.20-353,3575,504,905-6%-$14,912,376
M
2024-03-11
KYMRKymera Therapeutics, Inc.Booth BruceDirS - Sale$42.20-353,357828,830-30%-$14,912,376
M
2024-03-11
FRTXFresh Tracks Therapeutics, Inc.Exploration Capital, LLC10%P - Purchase$0.92+16,3291,010,842+2%+$14,951
DM
2024-03-12
HALOHalozyme Therapeutics, Inc.Labarre Michael J.SVP, CHIEF TECHNICAL OFFICERS - Sale+OE$41.96-20,000156,558-11%-$839,100
DM
2024-03-11
RVMDRevolution Medicines, Inc.Horn Margaret ACOOS - Sale+OE$34.04-23,671142,467-14%-$805,652
2024-03-11
VCELVericel CorpHalpin MichaelCOOS - Sale$44.71-7,874949-89%-$352,047
2024-03-11
CDTXCidara Therapeutics, Inc.Tari LeslieCHIEF SCIENTIFIC OFFICERS - Sale$0.67-21,029260,165-7%-$14,085
2024-03-11
CDTXCidara Therapeutics, Inc.Sandison TaylorChief Medical OfficerS - Sale$0.67-20,662347,095-6%-$13,839
2024-03-11
CDTXCidara Therapeutics, Inc.Ward ShaneCOO, CLOS - Sale$0.67-20,473198,770-9%-$13,713
2024-03-11
CDTXCidara Therapeutics, Inc.Shah PreetamCFO, CBOS - Sale$0.67-18,931227,210-8%-$12,680
D
2024-03-12
JSPRJasper Therapeutics, Inc.Mahal Jeetinder SinghCOOS - Sale+OE$26.44-90025,009-3%-$23,792
D
2024-03-11
RGENRepligen CorpKuriyel RalfSVP, R, DS - Sale+OE$193.73-3,51724,260-13%-$681,348
DM
2024-03-08
NBIXNeurocrine Biosciences IncPops Richard FDirS - Sale+OE$140.04-1,80029,512-6%-$252,078
DM
2024-03-08
NBIXNeurocrine Biosciences IncDelaet IngridChief Regulatory OfficerS - Sale+OE$140.03-2,0007,507-21%-$280,053
DM
2024-03-11
CRSPCrispr Therapeutics AGKasinger James R.GC, SecretaryS - Sale+OE$77.15-3,94761,174-6%-$304,515
DM
2024-03-11
CRSPCrispr Therapeutics AGKulkarni SamarthCEOS - Sale+OE$77.04-14,385408,122-3%-$1,108,263
A
2024-02-21
CHROChromocell Therapeutics CorpFriedberg Ezra MDirP - Purchase$6.00+16,667545,721+3%+$100,002
2024-03-11
KRYSKrystal Biotech, Inc.Krishnan SumaPres, R, D, 10%S - Sale$170.95-50,0003,303,144-1%-$8,547,719
2024-03-11
KRYSKrystal Biotech, Inc.Krishnan Krish SPres, CEO, 10%S - Sale$170.95-50,0003,303,144-1%-$8,547,719
D
2024-03-08
RGENRepligen CorpHunt AnthonyCEOS - Sale+OE$197.44-16,707185,249-8%-$3,298,632
2024-03-11
XFORX4 Pharmaceuticals, IncTaveras ArthurChief Scientific OfficerS - Sale$0.88-14,235234,301-6%-$12,552
2024-03-11
XFORX4 Pharmaceuticals, IncRagan PaulaPres, CEOS - Sale$0.88-49,678765,068-6%-$43,856
2024-03-11
XFORX4 Pharmaceuticals, IncMostafa Adam S.CFOS - Sale$0.88-52,5000-100%-$46,347
2024-03-11
XFORX4 Pharmaceuticals, IncDibiase MaryCOOS - Sale$0.88-15,409291,752-5%-$13,591
2024-03-08
SANASana Biotechnology, Inc.Yang Patrick YDirS - Sale$9.45-25,000149,250-14%-$236,300
2024-03-07
OTLKOutlook Therapeutics, Inc.Evanson JeffChief Commercial OfficerP - Purchase$0.42+62,484808,459+8%+$26,243
2024-03-08
DBVTDbv Technologies S.A.Tasse DanielCEOP - Purchase$0.83+17,09417,094New+$14,188
2024-03-07
VCELVericel CorpSiegal JonathanPrincipal Accounting OfficerS - Sale$45.00-1,6341,400-54%-$73,530
2024-03-08
VCELVericel CorpFlynn Sean C.SVP, GCS - Sale$45.33-8,115167-98%-$367,853
D
2024-03-07
TECHBio-Techne CorpNusse RoelandDirS - Sale+OE$76.98-10,40043,097-19%-$800,627
D
2024-03-08
MRNAModerna, Inc.Klinger Shannon ThymeGCS - Sale+OE$99.05-5449,267-6%-$53,884
D
2024-03-06
RXRXRecursion Pharmaceuticals, Inc.Gibson ChristopherCEOS - Sale+OE$11.73-61,3191,108,524-5%-$719,505
M
2024-03-06
HLVXHillevax, Inc.Kohli AdityaDirS - Sale$18.66-18,000825,776-2%-$335,872
DM
2024-03-06
IPSCCentury Therapeutics, Inc.Farid AdrienneChief Operations OfficerS - Sale+OE$5.04-53,515114,149-32%-$269,682
2024-03-06
TWSTTwist Bioscience CorpCho DennisSee RemarksS - Sale$37.43-27281,4560%-$10,181
2024-03-06
TWSTTwist Bioscience CorpWerner Robert F.Chief Accounting OfficerS - Sale$37.43-18143,6800%-$6,775
D
2024-03-06
TWSTTwist Bioscience CorpLeproust Emily M.CEOS - Sale+OE$37.43-1,487516,4090%-$55,658
2024-03-06
TWSTTwist Bioscience CorpGreen PaulaSVP of HRS - Sale$37.43-60092,850-1%-$22,458
2024-03-06
TWSTTwist Bioscience CorpBanyai WilliamSee RemarkS - Sale$37.43-549346,7550%-$20,549
2024-03-05
RXRXRecursion Pharmaceuticals, Inc.Borgeson BlakeDirS - Sale$12.06-20,0547,272,8090%-$241,805
D
2024-03-05
RGNXRegenxbio Inc.Pakola SteveChief Medical OfficerS - Sale+OE$28.36-12,878107,192-11%-$365,220
2024-01-30
ALLOAllogene Therapeutics, Inc.Parker Geoffrey M.CFOP - Purchase$3.60+190819,5900%+$683
2024-03-05
ADPTAdaptive Biotechnologies CorpPiskel KylePrincipal Accounting OfficerS - Sale$3.43-7,727123,318-6%-$26,504
D
2024-03-05
ADPTAdaptive Biotechnologies CorpTaylor Stacy LSVP, GCS - Sale+OE$3.43-13,381166,287-7%-$45,963
D
2024-03-05
ADPTAdaptive Biotechnologies CorpLo FrancisChief People OfficerS - Sale+OE$3.43-14,700256,245-5%-$50,439
D
2024-03-05
ADPTAdaptive Biotechnologies CorpBenzeno SharonChief Commercial Ofc Imm MedS - Sale+OE$3.44-29,390327,415-8%-$100,994
2024-03-05
ADPTAdaptive Biotechnologies CorpRubinstein JuliePresS - Sale$3.47-39,070472,754-8%-$135,764
2024-03-05
ADPTAdaptive Biotechnologies CorpPeterson TychoCFOS - Sale$3.44-15,456531,553-3%-$53,169
2024-03-05
ADPTAdaptive Biotechnologies CorpRobins Chad MCEO, COBS - Sale$3.43-48,6732,576,701-2%-$167,007
D
2024-03-05
ADPTAdaptive Biotechnologies CorpBobulsky SusanChief Commercial Officer, MRDS - Sale+OE$3.44-12,991248,290-5%-$44,629
2024-03-05
TNYATenaya Therapeutics, Inc.Hoey TimothyChief Scientific OfficerS - Sale$7.00-3,300245,346-1%-$23,101
2024-03-04
ATRAAtara Biotherapeutics, Inc.Touchon PascalPres, CEOS - Sale$0.72-24,8441,910,652-1%-$17,888
2024-03-04
ATRAAtara Biotherapeutics, Inc.Nguyen AnhcoEVP, Chief Sci., Tech OfficerS - Sale$0.72-10,746941,397-1%-$7,737
2024-03-04
ATRAAtara Biotherapeutics, Inc.Hyllengren Eric JEVP, CFOS - Sale$0.72-6,679674,319-1%-$4,810
2024-03-04
ATRAAtara Biotherapeutics, Inc.Henrich JillEVP, Global Head RA, QualityS - Sale$0.72-3,879555,001-1%-$2,793
D
2024-03-04
DNAGinkgo Bioworks Holdings, Inc.Dmytruk Mark E.See RemarksS - Sale+OE$1.26-38,826808,125-5%-$48,765
D
2024-03-05
EDITEditas Medicine, Inc.O'Neill Gilmore NeilCEOS - Sale+OE$9.42-77,824327,470-19%-$732,884
D
2024-03-04
EDITEditas Medicine, Inc.Mei BaisongSVP, CHIEF MEDICAL OFFICERS - Sale+OE$9.42-20,327141,543-13%-$191,425
2024-03-04
ALECAlector, Inc.Grasso MarcCFOS - Sale$6.92-5,716144,957-4%-$39,562
2024-03-04
ALECAlector, Inc.Rosenthal ArnonCEOS - Sale$6.92-18,8375,930,7550%-$130,386
2024-03-04
ALECAlector, Inc.Romano GaryChief Medical OfficerS - Sale$6.92-6,001196,313-3%-$41,554
2024-03-04
ALECAlector, Inc.Kenkare-Mitra SaraPres, Head of R, DS - Sale$6.92-10,169318,847-3%-$70,387
D
2024-03-04
MRNAModerna, Inc.Klinger Shannon ThymeGCS - Sale+OE$94.34-1178,673-1%-$11,038
D
2024-03-04
MRNAModerna, Inc.Hoge StephenPresS - Sale+OE$94.34-3091,672,2900%-$29,151
D
2024-03-01
BLUEBluebird Bio, Inc.Colvin Richard AChief Medical OfficerS - Sale+OE$1.53-6,770118,368-5%-$10,342
D
2024-03-04
BLUEBluebird Bio, Inc.Obenshain AndrewPres, CEOS - Sale+OE$1.53-6,095279,998-2%-$9,311
D
2024-03-04
BLUEBluebird Bio, Inc.Klima Thomas JSee RemarksS - Sale+OE$1.53-4,573124,840-4%-$6,986
2024-03-04
FATEFate Therapeutics IncDulac Edward J IIICFOS - Sale$7.77-2,447101,479-2%-$19,013
D
2024-03-01
PCVXVaxcyte, Inc.Wassil JimCOOS - Sale+OE$73.71-3,000218,674-1%-$221,134
D
2024-03-01
PCVXVaxcyte, Inc.Cowan ElviaSVP, FinanceS - Sale+OE$74.08-11,67812,156-49%-$865,070
D
2024-03-01
PCVXVaxcyte, Inc.Eydelman MikhailSVP, GC, Corp SecS - Sale+OE$73.73-1,66730,597-5%-$122,907
D
2024-03-01
PCVXVaxcyte, Inc.Pickering GrantCEOS - Sale+OE$73.70-2,616561,5170%-$192,799
D
2024-03-04
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerS - Sale+OE$41.86-3,34495,740-3%-$139,967
D
2024-03-04
KYMRKymera Therapeutics, Inc.Jacobs Bruce N.CFOS - Sale+OE$41.86-3,934142,351-3%-$164,664
D
2024-02-28
KRYSKrystal Biotech, Inc.Romano KathrynChief Accounting OfficerS - Sale+OE$165.88-5,00015,622-24%-$829,417
D
2024-02-28
KRYSKrystal Biotech, Inc.Romano KathrynChief Accounting OfficerS - Sale+OE$166.05-7,50012,936-37%-$1,245,381
D
2024-02-29
MRNAModerna, Inc.Mock James MCFOS - Sale+OE$94.57-6474,300-13%-$61,188
D
2024-02-29
MRNAModerna, Inc.Klinger Shannon ThymeGCS - Sale+OE$94.57-6708,557-7%-$63,363
D
2024-02-29
MRNAModerna, Inc.Hoge StephenPresS - Sale+OE$94.57-2,3881,671,9470%-$225,838
D
2024-02-28
IMCRImmunocore Holdings PlcBerman David MHEAD OF R, DS - Sale+OE$68.59-36,5090-100%-$2,504,158
DM
2024-02-28
NBIXNeurocrine Biosciences IncDelaet IngridChief Regulatory OfficerS - Sale+OE$135.34-6,8177,507-48%-$922,632

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top